| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.5 | 7e-24 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-14 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |